Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring
Ji Eun Kim · 2026
Read Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring by Ji Eun Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13434515.txt.
Description
Ji Eun Kim discusses a paradox of bowel disease therapy in 2026: drugs that block a key swelling signal can spark fresh immune illness. A Korean study using national health records links the drugs to new cases of psoriasis and lung tissue disease. Risk rose soon after exposure began, then leveled off.
Skin change in the form of psoriasis is the most often reported twist. The piece links the effect to a shift in immune balance toward other pathways. Early onset hints that some patients carry the risk from the start. Clinicians are urged to watch skin and lungs closely in the first months of therapy.
Catalog record
| CREATOR | Ji Eun Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |